SCHEMBL13265948

SCHEMBL13265948

Cc1cc(NC(=O)c2ccccc2Sc2ccc(N)cc2)on1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.58
▸ SMN1; SMN2 Q16637 4/20 0.58
▸ GLA P06280 1/20 0.58
▸ GCK P35557 2/20 0.44
▸ ALOX15 P16050 2/20 0.43
▸ MAPK1 P28482 1/20 0.43
▸ PKM P14618 2/20 0.43
▸ EDNRA P25101 1/20 0.43
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ MAPT P10636 2/20 0.41
▸ NPC1 O15118 2/20 0.41
▸ RAB9A P51151 2/20 0.41
▸ TP53 P04637 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ HPGD P15428 2/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ HSD17B10 Q99714 1/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ ATF1 P18846 1/20 0.40
▸ NFKB1 P19838 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13265940 0.85 ALDH1A1 (0.54) ALDH1A1SMN1; SMN2GLAPKMMAPT
SCHEMBL13265974 0.78 SMN1; SMN2 (0.59) ALDH1A1SMN1; SMN2GLAPKMEDNRA
SCHEMBL13265785 0.77 SMN1; SMN2 (0.58) ALDH1A1SMN1; SMN2GLAGCKMAPK1
SCHEMBL618503 0.75 SLC6A3 (0.54) L3MBTL1KMT2AHPGDCYP2C9CYP2C19
SCHEMBL13265841 0.71 TSHR (0.67) ALDH1A1SMN1; SMN2MAPK1PKML3MBTL1
SCHEMBL13265834 0.70 SMN1; SMN2 (0.68) ALDH1A1SMN1; SMN2ALOX15PKML3MBTL1
SCHEMBL9625755 0.70 SIRT1 (0.58) ALDH1A1SMN1; SMN2MAPK1L3MBTL1MAPT
SCHEMBL6630665 0.68 SIRT1 (0.77) ALDH1A1SMN1; SMN2MAPK1L3MBTL1MAPT
SCHEMBL13265939 0.68 NPC1 (0.65) ALDH1A1SMN1; SMN2PKML3MBTL1NPC1
SCHEMBL13265770 0.68 SMN1; SMN2 (0.53) ALDH1A1SMN1; SMN2PKMMAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7754773-B2 Composition and synthesis of new reagents for inhibition of HIV replication UNIVERSITY OF MASSACHUSETTS (US) 2010-07-13 — — US disclosed
US-20070099919-A1 Composition and synthesis of new reagents for inhibition of HIV replication NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2007-05-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070099919-A1 Composition and synthesis of new reagents for inhibition of HIV replication REV1, MAVS, ISG15 ALDH1A1 4359/4885SMN1; SMN2 4378/4885GLA 4106/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback